Inclusion Criteria:  All women > 18 years of age Stage IV breast cancer undergoing cancer treatment  Exclusion Criteria:  Stage I-III breast cancer Unwilling or unable to give consent Patients with a prior or concurrent malignancy, excluding non-melanoma skin cancers and non-invasive cancers whose natural history or treatment does not have the potential to interfere with the assessment of the investigational marker